AKILI, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4272 USD | -3.87% |
|
+6.37% | -12.30% |
| 04-30 | Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product | CI |
| 04-30 | Akili, Inc. to Reduce Workforce | CI |
Chart calendar Akili, Inc.
9b3c468990ff8a5a15d05ea801.mWFawGfJgZPz32AKiBYqPvsRkQBQnW2SaNiUA1N_rwI.qFQupx3w3qGW7Sph10ZYR4tJ4FgpwiTVW531UQstn3ChVDbzXoXR_YGTEw~c9f63a394403ef543cfbe9446c40834a
Upcoming events on Akili, Inc.
Past events on Akili, Inc.
| 17/04/2024 15:00 | Annual General Meeting |
| 04/03/2024 17:50 | TD Cowen Health Care Conference - Fireside Chat |
| 29/02/2024 21:01 | Q4 2023 Earnings Release |
| 09/11/2023 21:30 | Q3 2023 Earnings Call |
| 09/11/2023 21:02 | Q3 2023 Earnings Release |
| 14/09/2023 13:30 | Business Update Call |
| 10/08/2023 21:30 | Q2 2023 Earnings Call |
| 10/08/2023 21:01 | Q2 2023 Earnings Release |
| 01/06/2023 | Elevate Psych Congress |
| 30/05/2023 | American Society of Clinical Psychopharmacology Meeting |
| 11/05/2023 21:30 | Q1 2023 Earnings Call |
| 11/05/2023 21:01 | Q1 2023 Earnings Release |
| 02/05/2023 15:00 | Annual General Meeting |
| 08/03/2023 14:50 | Cowen Health Care Conference - Fireside Chat |
| 07/03/2023 21:30 | Q4 2022 Earnings Call |
| 07/03/2023 21:01 | Q4 2022 Earnings Release |
| 11/01/2023 17:00 | Biotech Showcase |
| 10/01/2023 | Solebury 1x1 Management Access Conference |
| 10/11/2022 21:30 | Q3 2022 Earnings Call |
| 10/11/2022 21:01 | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,32 0,32 0.4% | 1,68 1,85 -9.4% | 7,64 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -78,0 -80,3 2.83% | -64,2 -55,0 -16.63% | -38,0 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -78,3 -86,2 9.16% | -64,5 -55,3 -16.52% | -38,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -7,95 -22,0 63.89% | -59,4 -64,2 7.4% | 0,00 |
|
Net income Million USD | Released Forecast Spread | -127 | -7,96 -90,2 91.17% | -59,5 -64,2 7.32% | 0,00 |
|
EPS USD | Released Forecast Spread | -106 | -0,64 -1,24 48.39% | -0,76 -0,88 13.64% | 0,00 |
| Announcement Date | 04/04/22 | 07/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,08 0,05 54.72% | 0,11 0,11 -1.55% | 0,11 0,20 -42.85% | 0,11 0,24 -52.04% | 0,70 0,32 117.34% | 0,75 0,78 -3.35% | 0,79 | 0,87 | 0,95 | 1,03 | 1,19 |
|
EBITDA Million USD | Released Forecast Spread | -18,2 -20,4 10.61% | -19,9 -21,5 7.26% | -12,0 -16,7 28.07% | -18,4 -16,2 -13.28% | -11,6 -14,2 18.61% | -10,0 | -9,32 | -9,28 | -8,64 | -8,54 | |
|
EBIT Million USD | Released Forecast Spread | -18,3 -21,8 15.93% | -20,0 -23,6 15.21% | -19,1 -17,2 -11.25% | -15,3 -16,0 4.17% | -18,4 -18,1 -1.74% | -11,6 -14,3 18.72% | -10,1 | -9,40 | -9,35 | -8,72 | -8,62 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 53,2 -21,0 353.5% | -15,9 -18,1 12.14% | -11,1 -13,7 18.73% | ||||||||
|
Net income Million USD | Released Forecast Spread | 53,2 -21,0 353.5% | -16,8 -22,4 24.9% | -20,7 -15,3 -35.63% | -11,8 -16,8 30.03% | -15,9 -18,1 12.14% | -11,1 -16,5 32.45% | -11,2 | -10,5 | -10,4 | -9,80 | -9,76 |
|
EPS USD | Released Forecast Spread | 0,76 -0,26 392.31% | -0,48 -0,29 -65.52% | -0,27 -0,20 -35% | -0,15 -0,20 25% | -0,20 -0,25 20% | -0,14 -0,23 39.13% | -0,14 | -0,13 | -0,13 | -0,12 | -0,12 |
| Announcement Date | 10/11/22 | 07/03/23 | 12/05/23 | 10/08/23 | 09/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for Akili, Inc.
| 09/05/2024 | OLYMPUS CORPORATION: Q4 2024 Earnings Release |
| 08/05/2024 | JEISYS MEDICAL INC.: Q1 2024 Earnings Release (Projected) |
| 08/05/2024 21:05 | CYTEK BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:01 | STANDARD BIOTOOLS INC.: Q1 2024 Earnings Release |
| 08/05/2024 06:00 | CARL ZEISS MEDITEC AG: Q2 2024 Earnings Release |
| 07/05/2024 | CLASSYS INC.: Q1 2024 Earnings Release |
| 07/05/2024 21:00 | QUANTERIX CORPORATION: Q1 2024 Earnings Release |
| 07/05/2024 11:50 | WATERS CORPORATION: Q1 2024 Earnings Release |
| 07/05/2024 06:00 | SIEMENS HEALTHINEERS AG: Q2 2024 Earnings Release |
| 02/05/2024 21:05 | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AKLI Stock
- Calendar Akili, Inc.
